Company: GEHC
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001628280-25-017240
Chunk: 2

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 2
---
May 28, 2025 at 9:00 a.m. Central Time

Location:

Virtual via live webcast at: www.virtualshareholdermeeting.com/GEHC2025

Record Date:

Stockholders of record at the close of business on March 31, 2025 are entitled to attend and vote at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”). On that date, there were 457,843,185 shares of common stock of GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “we,” “us,” or “our”) outstanding and entitled to vote.

#### Voting Matters and Board Recommendations
Stockholders will be asked to vote on the following matters at the Annual Meeting. Whether or not you plan to attend the Annual Meeting, we encourage you to promptly submit your proxy with your voting instructions. You may do this over the internet, as well as by telephone or mail. See “Voting and Meeting Information” on page 80. The Company’s Board of Directors (the “Board”) is not aware of any matter that will be presented for a vote at the Annual Meeting other than those shown below.

| Management Proposal  
 1                    |     |                                                                                                                                                                                               |     | Election of the 10 Director Nominees Named in this Proxy Statement for a One-Year Term                                                                                                       
 At the Annual Meeting, ten director nominees will stand for election to hold office until the 2026 Annual Meeting of Stockholders or until their successors have been elected and qualified. |
|                      |     | The Board recommends a vote FOR each director nominee                                                                                                                                         |     | See Page9                                                                                                                                                                                    |
| ManagementProposal   
 2                    |     |                                                                                                                                                                                               |     | Approval of Our Named Executive Officers’ Compensation in an Advisory Vote                                                                                                                   
 We are asking stockholders to approve, on an advisory basis, the compensation paid to our named executive officers (“NEOs”) in 2024, as described in this proxy statement.                   |
|                      |     | The Board recommends a vote FOR the say-on-pay proposal                                                                                                                                       |     | See Page36                                                                                                                                                                                   |
| ManagementProposal   
 3                    |     |                                                                                                                                                                                               |     | Ratification of the Appointment of Deloitte & Touche LLP as Our Independent Auditor for the Fiscal Year Ending December 31, 2025                                                             
 We are asking stockholders to ratify the selection of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 202